CDKN1A and plasma cell myeloma: Neither BIM nor p21 protein levels appears to be affected by MAGE-A silencing in p53 null HMCL, but these cells still undergo apoptosis under these conditions, indicating that MAGE-A regulate at least one additional p53-independent survival pathway in myeloma cells.